ImageneBio, Inc.
IMA· Nasdaq
Released Mar 10, 2026, before the open
10-K filed Mar 10, 2026, 69 days after period end · 0001193125-26-099434
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | $658.00K | $5.45M |
| Net Income | -$6.91M |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$4.81M |
| -$19.49M |
| -$14.10M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.